Hugin Ad hoc announcement according to 15 WpHG: Acquisition: Evotec AG: PerkinElmer to Acquire Evotec Technologies.

(From Hugin)

Ad-hoc announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) today announced that the Company has signed a definitive agreement with PerkinElmer pursuant to which PerkinElmer will acquire Evotec Technologies GmbH, Hamburg, Germany, in a cash transaction valued at approximately EUR 23 million. Evotec Technologies is a majority owned subsidiary of Evotec AG. The transaction is subject to regulatory approvals and other customary closing conditions and closing is expected to occur late December 2006 or early 2007. Evotec Technologies will be deconsolidated from Evotec's group financial statements as of 01.01.2007. This transaction is another milestone in Evotec's strategy to focus the Company on its core business - drug discovery and development. Together with the sale of single molecule detection technologies and patents to Olympus earlier in the year, the combined divestments value Evotec Technologies at approximately EUR 30 million. The cash proceeds will provide Evotec with additional flexibility to progress and expand its Central Nervous System pipeline. Excluding ...